Novartis

Based in Switzerland, the world’s top-selling pharmaceuticals company has time and again made groundbreaking advances in the many areas in which it works. Born of a merger between Ciba-Geigy and Sandoz in 1996, the company has since embarked on a mission to ‘care and cure’ those in the 150 countries in which it operates. The Novartis Institute for BioMedical Research (NIBR) represents an important part of the company’s innovative streak and underpins its ability to continually improve upon its existing products and services. The company’s updated strategy has seen it adopt a more focused portfolio based on greater profit-making possibilities going forward.